# Body PSOriasis: Long-term Relapse CONTROL

> **NCT03402828** · — · COMPLETED · sponsor: **LEO Pharma** · enrollment: 764 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Any topical drug treatment

## Key facts

- **NCT ID:** NCT03402828
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-11
- **Primary completion:** 2020-05-15
- **Final completion:** 2020-05-15
- **Target enrollment:** 764 (ACTUAL)
- **Last updated:** 2021-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03402828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03402828, "Body PSOriasis: Long-term Relapse CONTROL". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03402828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*